89 related articles for article (PubMed ID: 3823635)
1. High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study.
Gulsvik A; Kjelsberg F; Bergmann A; Frøland SS; Rootwelt K; Vale JR
Respiration; 1986; 50(4):252-7. PubMed ID: 3823635
[TBL] [Abstract][Full Text] [Related]
2. Gallium-67 scanning in the staging of cryptogenetic fibrosing alveolitis and hypersensitivity pneumonitis.
Vanderstappen M; Mornex JF; Lahneche B; Chauvot P; Bouvier JF; Wiesendanger T; Pages J; Webert P; Cordier JF; Brune J
Eur Respir J; 1988 Jun; 1(6):517-22. PubMed ID: 3169221
[TBL] [Abstract][Full Text] [Related]
3. Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study.
Agustí C; Xaubet A; Ballester E; Alarcón A; Picado C
Thorax; 1993 Jan; 48(1):68-9. PubMed ID: 8434357
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
Kondoh Y; Taniguchi H; Yokoi T; Nishiyama O; Ohishi T; Kato T; Suzuki K; Suzuki R
Eur Respir J; 2005 Mar; 25(3):528-33. PubMed ID: 15738299
[TBL] [Abstract][Full Text] [Related]
5. Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis.
Johnson MA; Kwan S; Snell NJ; Nunn AJ; Darbyshire JH; Turner-Warwick M
Thorax; 1989 Apr; 44(4):280-8. PubMed ID: 2669218
[TBL] [Abstract][Full Text] [Related]
6. The predictive value of appearances on thin-section computed tomography in fibrosing alveolitis.
Wells AU; Hansell DM; Rubens MB; Cullinan P; Black CM; du Bois RM
Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1076-82. PubMed ID: 8214928
[TBL] [Abstract][Full Text] [Related]
7. Measures of the inflammatory response in cryptogenic fibrosing alveolitis.
Pantin CF; Valind SO; Sweatman M; Lawrence R; Rhodes CG; Brudin L; Britten A; Hughes JM; Turner-Warwick M
Am Rev Respir Dis; 1988 Nov; 138(5):1234-41. PubMed ID: 3144213
[TBL] [Abstract][Full Text] [Related]
8. Standardized quantitative 67Ga scintigraphy in relation to carbon monoxide diffusion capacity in pulmonary sarcoidosis.
Kuipers AF; Alberts C; Roos CM; van der Schoot JB; Jansen HM
Sarcoidosis; 1993 Mar; 10(1):36-40. PubMed ID: 8134713
[TBL] [Abstract][Full Text] [Related]
9. Effect of intermittent high dose parenteral corticosteroids on the alveolitis of idiopathic pulmonary fibrosis.
Keogh BA; Bernardo J; Hunninghake GW; Line BR; Price DL; Crystal RG
Am Rev Respir Dis; 1983 Jan; 127(1):18-22. PubMed ID: 6849542
[TBL] [Abstract][Full Text] [Related]
10. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
Liossis SN; Bounas A; Andonopoulos AP
Rheumatology (Oxford); 2006 Aug; 45(8):1005-8. PubMed ID: 16490756
[TBL] [Abstract][Full Text] [Related]
12. British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.
Rudd RM; Prescott RJ; Chalmers JC; Johnston ID;
Thorax; 2007 Jan; 62(1):62-6. PubMed ID: 16769717
[TBL] [Abstract][Full Text] [Related]
13. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.
Vanthuyne M; Blockmans D; Westhovens R; Roufosse F; Cogan E; Coche E; Nzeusseu Toukap A; Depresseux G; Houssiau FA
Clin Exp Rheumatol; 2007; 25(2):287-92. PubMed ID: 17543155
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic interstitial pneumonitis presenting with Wells grade III. Can imaging methods help predict further progression of disease?].
Fasano L; Zompatori M; Monetti N; Battista G; Pacilli AM; Scioscio V Di; Sciascia N
Radiol Med; 1999 Oct; 98(4):268-74. PubMed ID: 10615366
[TBL] [Abstract][Full Text] [Related]
15. Fibrosing alveolitis: prognostic implication of ground-glass attenuation at high-resolution CT.
Lee JS; Im JG; Ahn JM; Kim YM; Han MC
Radiology; 1992 Aug; 184(2):451-4. PubMed ID: 1620846
[TBL] [Abstract][Full Text] [Related]
16. Serial pulmonary function tests in fibrosing alveolitis.
Benson MK; Hughes DT
Br J Dis Chest; 1972 Jan; 66(1):33-44. PubMed ID: 5017931
[No Abstract] [Full Text] [Related]
17. Fibrosing alveolitis.
Thomas P
Can Med Assoc J; 1978 Nov; 119(10):1211-6. PubMed ID: 369671
[TBL] [Abstract][Full Text] [Related]
18. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.
Hoyles RK; Ellis RW; Wellsbury J; Lees B; Newlands P; Goh NS; Roberts C; Desai S; Herrick AL; McHugh NJ; Foley NM; Pearson SB; Emery P; Veale DJ; Denton CP; Wells AU; Black CM; du Bois RM
Arthritis Rheum; 2006 Dec; 54(12):3962-70. PubMed ID: 17133610
[TBL] [Abstract][Full Text] [Related]
19. Different therapies and factors influencing response to therapy in idiopathic diffuse fibrosing alveolitis.
Costabel U; Matthys H
Respiration; 1981; 42(3):141-9. PubMed ID: 7313338
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous pneumothorax in cryptogenic fibrosing alveolitis.
Picado C; Gómez de Almeida R; Xaubet A; Montserrat J; Letang E; Sánchez-Lloret J
Respiration; 1985; 48(1):77-80. PubMed ID: 4023442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
